A detailed history of Lee Financial CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Lee Financial CO holds 12,844 shares of ABBV stock, worth $2.16 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
12,844
Previous 12,972 0.99%
Holding current value
$2.16 Million
Previous $2.01 Million 16.32%
% of portfolio
0.39%
Previous 0.35%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $20,456 - $23,308
-128 Reduced 0.99%
12,844 $2.34 Million
Q4 2023

Feb 08, 2024

SELL
$137.6 - $154.97 $14,585 - $16,426
-106 Reduced 0.81%
12,972 $2.01 Million
Q3 2023

Nov 09, 2023

SELL
$133.59 - $154.65 $118,227 - $136,865
-885 Reduced 6.34%
13,078 $1.95 Million
Q2 2023

Aug 08, 2023

SELL
$132.51 - $164.9 $171,600 - $213,545
-1,295 Reduced 8.49%
13,963 $1.88 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $214,312 - $246,812
-1,482 Reduced 8.85%
15,258 $2.43 Million
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $23,236 - $27,866
168 Added 1.01%
16,740 $2.71 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $42,544 - $48,795
317 Added 1.95%
16,572 $2.22 Million
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $87,801 - $111,624
-638 Reduced 3.78%
16,255 $2.49 Million
Q1 2022

May 11, 2022

SELL
$131.98 - $163.75 $228,853 - $283,942
-1,734 Reduced 9.31%
16,893 $2.74 Million
Q4 2021

Feb 08, 2022

SELL
$107.43 - $135.93 $13,428 - $16,991
-125 Reduced 0.67%
18,627 $2.52 Million
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $32,664 - $37,079
307 Added 1.66%
18,752 $2.02 Million
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $35,771 - $39,851
-340 Reduced 1.81%
18,445 $2.08 Million
Q1 2021

May 13, 2021

SELL
$102.3 - $112.62 $34,986 - $38,516
-342 Reduced 1.79%
18,785 $2.03 Million
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $8,531 - $11,519
106 Added 0.56%
19,127 $2.05 Million
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $22,078 - $25,913
257 Added 1.37%
19,021 $1.67 Million
Q2 2020

Aug 11, 2020

SELL
$73.37 - $98.18 $10,785 - $14,432
-147 Reduced 0.78%
18,764 $1.84 Million
Q1 2020

May 07, 2020

SELL
$64.5 - $97.79 $4,257 - $6,454
-66 Reduced 0.35%
18,911 $1.44 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $360 - $451
-5 Reduced 0.03%
18,977 $1.68 Million
Q3 2019

Nov 08, 2019

BUY
$62.98 - $75.72 $176,406 - $212,091
2,801 Added 17.31%
18,982 $1.44 Million
Q2 2019

Jul 30, 2019

SELL
$65.7 - $83.98 $3,942 - $5,038
-60 Reduced 0.37%
16,181 $1.18 Million
Q1 2019

Apr 30, 2019

BUY
$77.14 - $90.79 $12,419 - $14,617
161 Added 1.0%
16,241 $1.31 Million
Q4 2018

Feb 11, 2019

SELL
$77.85 - $96.01 $21,486 - $26,498
-276 Reduced 1.69%
16,080 $1.48 Million
Q3 2018

Nov 07, 2018

SELL
$88.91 - $98.84 $15,470 - $17,198
-174 Reduced 1.05%
16,356 $1.55 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $40,760 - $48,228
-454 Reduced 2.67%
16,530 $1.53 Million
Q1 2018

May 09, 2018

SELL
$92.01 - $123.21 $204,722 - $274,142
-2,225 Reduced 11.58%
16,984 $1.61 Million
Q4 2017

Feb 09, 2018

SELL
$89.56 - $98.21 $35,376 - $38,792
-395 Reduced 2.01%
19,209 $1.86 Million
Q3 2017

Nov 07, 2017

BUY
$69.85 - $89.22 $1.37 Million - $1.75 Million
19,604
19,604 $1.74 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lee Financial CO Portfolio

Follow Lee Financial CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

News

Stay updated on Lee Financial CO with notifications on news.